Find clinical trials for Diabetes in Cleveland, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Cleveland, OH, USA:
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Cleveland, Ohio, United States and 17 other locations
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Cleveland, Ohio, United States and 26 other locations
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
Cleveland, Ohio, United States and 78 other locations
Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study.A multi-center, double-blinded, ...
Cleveland, Ohio, United States and 6 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Mentor, Ohio, United States and 227 other locations
glucose monitoring sensor called Disposable Sensor 5 in people with diabetes. The study will include people with Type 1 diabetes wh...
Cleveland, Ohio, United States and 31 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Beachwood, Ohio, United States and 96 other locations
This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...
Phase 4
Cleveland, Ohio, United States and 39 other locations
5 SmartAdjust 2.0 System in individuals with type 1 or type 2 diabetes.Study participants will complete about 5 in-person visits and be expe...
Cleveland, Ohio, United States and 10 other locations
delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes...
Phase 3
Cleveland, Ohio, United States and 15 other locations
Clinical trials
Research sites
Resources
Legal